Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2008

Apr 2, 2008

30339_dirs_2008-04-02_cbef9c4b-0c5c-4491-bdab-1383f97cf708.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2008-03-31

Reporting Person: ELLERS STEVEN A (COO & President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-03-31 Common Stock M 40000 $11.295 Acquired 164913.7486 Direct
2008-03-31 Common Stock F 22302 $44.23 Disposed 142611.7486 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-03-31 Stock Option (Right to Buy) $11.295 M 40000 Disposed 2008-04-28 Common Stock (40000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2880.6039 Indirect
Common Stock 32608.4005 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.